Philip Astley-sparke - Net Worth and Insider Trading
Philip Astley-sparke Net Worth
The estimated net worth of Philip Astley-sparke is at least $11 Million dollars as of 2024-06-07. Philip Astley-sparke is the Executive Chairman of Replimune Group Inc and owns about 1,487,350 shares of Replimune Group Inc (REPL) stock worth over $11 Million. Philip Astley-sparke is also the Director of uniQure NV and owns about 9,946 shares of uniQure NV (QURE) stock worth over $52,813. Details can be seen in Philip Astley-sparke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Philip Astley-sparke has not made any transactions after 2024-05-16 and currently still holds the listed stock(s).
Transaction Summary of Philip Astley-sparke
Philip Astley-sparke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Philip Astley-sparke owns 3 companies in total, including Replimune Group Inc (REPL) , uniQure NV (QURE) , and Forbion European Acquisition Corp (FRBN) .
Click here to see the complete history of Philip Astley-sparke’s form 4 insider trades.
Insider Ownership Summary of Philip Astley-sparke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REPL | Replimune Group Inc | 2024-05-16 | director & 10 percent owner & Executive Chairman |
| QURE | uniQure NV | 2021-03-02 | director |
| FRBN | Forbion European Acquisition Corp | 2021-12-09 | director |
Philip Astley-sparke Latest Holdings Summary
Philip Astley-sparke currently owns a total of 2 stocks. Among these stocks, Philip Astley-sparke owns 1,487,350 shares of Replimune Group Inc (REPL) as of May 16, 2024, with a value of $11 Million and a weighting of 99.5%. Philip Astley-sparke also owns 9,946 shares of uniQure NV (QURE) as of March 2, 2021, with a value of $52,813 and a weighting of 0.5%.
Latest Holdings of Philip Astley-sparke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REPL | Replimune Group Inc | 2024-05-16 | 1,487,350 | 7.11 | 10,575,059 |
| QURE | uniQure NV | 2021-03-02 | 9,946 | 5.31 | 52,813 |
Holding Weightings of Philip Astley-sparke
Philip Astley-sparke Form 4 Trading Tracker
According to the SEC Form 4 filings, Philip Astley-sparke has made a total of 9 transactions in Replimune Group Inc (REPL) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Replimune Group Inc is the sale of 37,928 shares on May 16, 2024, which brought Philip Astley-sparke around $245,394.
According to the SEC Form 4 filings, Philip Astley-sparke has made a total of 3 transactions in uniQure NV (QURE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in uniQure NV is the sale of 504 shares on March 2, 2021, which brought Philip Astley-sparke around $18,950.
Insider Trading History of Philip Astley-sparke
- 1
Philip Astley-sparke Trading Performance
Philip Astley-sparke Ownership Network
Philip Astley-sparke Owned Company Details
What does Replimune Group Inc do?
Who are the key executives at Replimune Group Inc?
Philip Astley-sparke is the director & 10 percent owner & Executive Chairman of Replimune Group Inc. Other key executives at Replimune Group Inc include Chief Commercial Officer Christopher Sarchi , Chief Accounting Officer Andrew Schwendenman , and Chief Medical Officer Konstantinos Xynos .
Replimune Group Inc (REPL) Insider Trades Summary
Over the past 18 months, Philip Astley-sparke made 2 insider transaction in Replimune Group Inc (REPL) with a net sale of 55,830. Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 66,624 shares made by Pamela Esposito , a net sale of 41,467 shares made by Sushil Patel , and a net sale of 14,451 shares made by Konstantinos Xynos .
In summary, during the past 3 months, insiders sold 98,084 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 98,084 shares. During the past 18 months, 272,276 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 272,276 shares.
Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Replimune Group Inc Insider Transactions
Philip Astley-sparke Mailing Address
Above is the net worth, insider trading, and ownership report for Philip Astley-sparke. You might contact Philip Astley-sparke via mailing address: C/o Biovex Group, Inc., 34 Commerce Way, Woburn Ma 10801.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
